Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis’ Cox-II challenger suffers set back

October 28, 2003

Prexige, the new challenger to the established Cox-II drugs from Novartis has been dealt a serious blow after the FDA …

News

Hassan takes on Schering-Plough revival

October 28, 2003

Fred Hassan has outlined his plans to turn round the fortunes of struggling Schering-Plough after being installed as the company's …

News

Swiss franc undercuts Roche growth

October 28, 2003

Sales revenues at Roche have been dealt a serious blow by currency fluctuations in the first quarter, with a strong …

News

Ageing atypical could help cut suicide levels

October 28, 2003

Novartis' atypical antipsychotic Clozaril could lead to a reduction in suicide rate among patients suffering from schizophrenia, according to a …

News

Patent system damaging research

October 28, 2003

The UK patent system is damaging scientific research and creating a old rush mentality according to the Royal Society.The current …

News

Outlook improving for GSK

October 28, 2003

News

Human genome sequence completed

October 28, 2003

The project to decode the human genome has been completed two years ahead of schedule, but scientists have warned against …

News

GSK claims victory in US parallel import row

October 27, 2003

GlaxoSmithKline has claimed victory in its controversial bid to block parallel imports of its drugs from Canada into the US.The …

News

Swiss franc undercuts Roche growth

October 27, 2003

Sales revenues at Roche have been dealt a serious blow by currency fluctuations in the first quarter, with a strong …

News

Patent system damaging research

October 27, 2003

The UK patent system is damaging scientific research and creating a "gold rush mentality", according to the Royal Society.The current …

News

NHS gamble could fail, Blair advisor warns

October 27, 2003

News

Human genome sequence completed

October 27, 2003

The project to decode the human genome has been completed two years ahead of schedule, but scientists have warned against …

News

Humira launch costs hit Abbott

October 27, 2003

Abbott Labs recorded a 6% drop in profits for the first quarter of 2003 following heavy spending on the launch …

News

OGS takeover battle nears conclusion

October 27, 2003

News

New CHAI head quits

October 27, 2003

News

Set back for GSK in Augmentin court battle

October 27, 2003

GlaxoSmithKline has suffered a set back in its bid to see off early US generic competition for antibiotic Augmentin, one …

News

MEPs vote to ban embryonic stem cell research

October 27, 2003

European MPs have voted to ban the use of human cloning and embryonic stem cells for research purposes.The vote could …

News

Evans says no to OGS

October 27, 2003

News

Ministers cleared of vaccine contract misconduct

October 27, 2003

News

Merlin on track to buy ReNeuron

October 27, 2003

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025